Prostate Cancer Video Channel
Explore the latest insights and summaries from experts in Prostate Cancer.
Therapeutic Agents
Alice Bernard-Tessier
Searching for I-O in Prostate Cancer: Unraveling the Role of Immunotherapy
- 156 views
- May 10, 2024
Cedars Sinai
Comparing Adverse Event Rates by Race Among ADT-Treated vs. Non-ADT-Treated Prostate Cancer Patients
FEATURING
Nadine Friedrich
- 177 views
- August 27, 2024
Penn Medicine Abramson Cancer Center
Improving QoL During and After Treatment in Prostate Cancer
FEATURING
Cailyn Chow,
Robert Caleb Kovell
- 46 views
- November 15, 2024
- 1
University of Illinois Cancer Center
Practical Considerations for PSMA-Targeted Therapy in Prostate Cancer
FEATURING
Karine Tawagi,
Natalie Reizine
- 169 views
- December 2, 2024
- 5
Yale Cancer Center
Theranostics and Advanced Treatment Options for Prostate Cancer
FEATURING
Gabriela Spilberg
- 114 views
- May 6, 2024
Insights from AUA 2024 Annual Meeting
AUA 2024 Insights: "Manipulating the Androgen Axis - New Agents in mHSPC and CRPC"
FEATURING
David Jarrard
- 383 views
- May 23, 2024
- 3
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "CYCLONE 2 Study - Abemaciclib + Abiraterone in mCRPC"
FEATURING
Tilman Todenhöfer
- 57 views
- June 19, 2024
ecancer
ASCO® 2024 Insights: "PSMAfore - HRQoL and Pain in Taxane-Naïve mCRPC Patients Treated with Lutetium-177-PSMA-617"
FEATURING
Karim Fizazi
- 79 views
- June 20, 2024
Miami Cancer Institute Precision Oncology Symposium
Precision Oncology in Metastatic Prostate Cancer: Genomic Markers and Theranostics
FEATURING
Rohan Garje
- 373 views
- June 26, 2024
- 3
The View on GU | with Lalani & Wallis
Review of Prostate Cancer Updates From ASCO® GU 2024
FEATURING
Aly-Khan A. Lalani,
Christopher Wallis
- 14 views
- September 5, 2024
Houston Methodist
Developing Local Delivery of Anti-Androgen Therapy: A Novel Treatment for Prostate Diseases
FEATURING
Pamela Munster
- 20 views
- September 19, 2024
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Insights: STAMPEDE2 Comparison P - Upfront Accelerated 177Lu-PSMA-617 in mHSPC
FEATURING
Minal Padden-Modi,
Nick James
- 68 views
- September 25, 2024
- 1
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Insights: INSPIRE Trial - Nivolumab and Ipilimumab in Molecularly Selected mCRPC Patients
FEATURING
Niven Mehra
- 126 views
- October 1, 2024
- 2
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Highlights of Radioligand Therapies in Prostate Cancer
FEATURING
Natalie Reizine,
Karine Tawagi
- 79 views
- October 10, 2024
- 1
ecancer
ESMO 2024 Insights: PEACE-3 Trial - Enzalutamide Treatment Boosted by Radium-223 in mCRPC
FEATURING
Silke Gillessen
- 57 views
- October 11, 2024
ecancer
ESMO 2024 Summary: Understanding the Use of PARPi Combinations to Treat Patients With mCRPC
- 25 views
- October 11, 2024
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Insights: Circulating Tumor Cell Enumeration and OS in mCRPC Treated With Xaluritamig
FEATURING
Andrew Armstrong
- 33 views
- October 14, 2024
International Urology Cancer Summit - IUCS
Evolving Strategies in First and Second-Line Treatment for mCRPC
FEATURING
Neeraj Agarwal
- 227 views
- October 23, 2024
- 2
Advanced Prostate Cancer Consensus Conference (APCCC)
PARP Inhibition (Dissected): Determining Who Benefits in mCRPC
FEATURING
Johann de Bono
- 52 views
- November 5, 2024
Advanced Prostate Cancer Consensus Conference (APCCC)
Best Use of PARP Inhibitors in mCRPC With BRCA1/2 Alterations
FEATURING
Joaquin Mateo
- 22 views
- November 5, 2024
Masonic Cancer Center, University of Minnesota
Targeting RET Kinase in Neuroendocrine Prostate Cancer
FEATURING
Justin Drake
- 12 views
- November 7, 2024
Advanced Prostate Cancer Consensus Conference (APCCC)
Managing mHSPC With Early Progression on Combination Therapy
FEATURING
Christopher Sweeney
- 6 views
- November 11, 2024
Advanced Prostate Cancer Consensus Conference (APCCC)
Managing Side Effects of PARP Inhibitors in mCRPC
FEATURING
Elena Castro
- 18 views
- November 12, 2024
Yale Cancer Center
Updates in Radioligand Therapies for Metastatic Prostate Cancer
FEATURING
William Oh
- 105 views
- November 20, 2024
- 1
University of Illinois Cancer Center
Diagnostic and Therapeutic Updates in mCRPC: Radioligand Therapy
FEATURING
Karine Tawagi
- 192 views
- March 5, 2024
- 5
University of Illinois Cancer Center
Overview of Homologous Recombination Deficiencies & PARPi in mCRPC
FEATURING
Karine Tawagi
- 269 views
- March 5, 2024
- 2
Dana-Farber Cancer Institute
Prostate Cancer Highlights From ASCO® GU 2024
FEATURING
Jacob Berchuck,
Atish Choudhury
- 335 views
- March 13, 2024
- 2
Jochen Walz
Management of Toxicities Associated With ARSi+ADT Therapy in mCSPC
- 178 views
- March 18, 2024
Maneesh Jain
Evaluating Safety and Efficacy of T-DXd as a Subsequent Line Therapy in HER2+ mCRPC
- 4 views
- December 11, 2024
University of Illinois Cancer Center
Shifting Paradigms in the Treatment of Metastatic Prostate Cancer
FEATURING
Karine Tawagi
- 10 views
- December 12, 2024